1. Home
  2. JAGX vs ATXG Comparison

JAGX vs ATXG Comparison

Compare JAGX & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • ATXG
  • Stock Information
  • Founded
  • JAGX 2013
  • ATXG 2014
  • Country
  • JAGX United States
  • ATXG China
  • Employees
  • JAGX N/A
  • ATXG N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • ATXG Professional Services
  • Sector
  • JAGX Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • JAGX 3.9M
  • ATXG 3.8M
  • IPO Year
  • JAGX N/A
  • ATXG N/A
  • Fundamental
  • Price
  • JAGX $1.77
  • ATXG $0.55
  • Analyst Decision
  • JAGX Strong Buy
  • ATXG
  • Analyst Count
  • JAGX 1
  • ATXG 0
  • Target Price
  • JAGX $60.00
  • ATXG N/A
  • AVG Volume (30 Days)
  • JAGX 147.1K
  • ATXG 129.6K
  • Earning Date
  • JAGX 08-14-2025
  • ATXG 08-14-2025
  • Dividend Yield
  • JAGX N/A
  • ATXG N/A
  • EPS Growth
  • JAGX N/A
  • ATXG N/A
  • EPS
  • JAGX N/A
  • ATXG N/A
  • Revenue
  • JAGX $11,810,000.00
  • ATXG $4,310,835.00
  • Revenue This Year
  • JAGX $22.41
  • ATXG N/A
  • Revenue Next Year
  • JAGX $30.00
  • ATXG N/A
  • P/E Ratio
  • JAGX N/A
  • ATXG N/A
  • Revenue Growth
  • JAGX 15.96
  • ATXG N/A
  • 52 Week Low
  • JAGX $1.57
  • ATXG $0.36
  • 52 Week High
  • JAGX $35.25
  • ATXG $1.86
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 39.90
  • ATXG 53.61
  • Support Level
  • JAGX $1.60
  • ATXG $0.44
  • Resistance Level
  • JAGX $1.70
  • ATXG $0.58
  • Average True Range (ATR)
  • JAGX 0.12
  • ATXG 0.05
  • MACD
  • JAGX 0.01
  • ATXG 0.01
  • Stochastic Oscillator
  • JAGX 37.04
  • ATXG 64.71

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: